The largest database of trusted experimental protocols

4 protocols using dmem 4 500 mg l glucose

1

Gene Silencing of p53 and TNF in TNBC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The experiments were performed using two TNBC cell lines Hs578T and MDA-MB-231, cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) 4,500 mg/L glucose (Sigma-Aldrich, St Louis, MO, USA) and RPMI-1640 (Sigma-Aldrich) medium, respectively. They were supplemented with 10% fetal bovine serum (Sigma-Aldrich), 1% l-glu-tamine solution, and 1% penicillin–streptomycin (both from Sigma-Aldrich). For gene silencing, we used siRNA-p53 and siRNA-TNF from Ambion (Austin, TX, USA). siPORT™ NeoFX™ Transfection Agent (Life Technologies, Carlsbad, CA, USA) was used to perform the transfection, according to the manufacturer’s protocol. The transfection was done simultaneously with cell plating. For further RT-PCR studies, we used a density of 5×105 cells/well in a total volume of 2 mL Opti-MEM I (Thermo Fisher Scientific, Waltham, MA, USA). For each well, we used 5 μL transfection agent and a final concentration of 40 nM siRNA. The cells were treated simultaneously with both siRNAs for p53 and TNF gene silencing. As a control, we used a scramble siRNA. Each experiment was performed in triplicate. Cells were incubated for 24 hours in a 5% CO2 incubator at 37°C and then lysed to isolate total RNA.
+ Open protocol
+ Expand
2

Breast and Ovarian Cancer Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human breast cancer cell lines, MCF-7 and MDA-MB-231 (ATCC), were maintained in Dulbecco’s Modified Eagle’s Media (DMEM, 4500 mg/L glucose, Sigma Aldrich) supplemented with 10% (v/v) fetal bovine serum (FBS; Thermo Fisher Scientific) and 1% (v/v) penicillin-streptomycin (PS; Thermo Fisher Scientific). The human ovarian cancer cell line, OVCAR-3 (ATCC), was cultured in Roswell Park Memorial Institute 1640 (RPMI 1640) media supplemented with 10% (v/v) FBS, 1% (v/v) PS, and 0.001% (w/v) bovine insulin (Sigma Aldrich). For cell growth analysis, cells were seeded at a density of 1 × 105 cells per well in 6-well plates or 35 mm dishes. Prior to counting, cells were singularized using 0.25% trypsin-EDTA (Thermo Fisher Scientific) and treated with a 1:1 ratio of Trypan blue (Thermo Fisher Scientific), after which the live cell number was determined using a Countess II FL automated cell counter (Thermo Fisher Scientific).
+ Open protocol
+ Expand
3

Isolation and Culture of Rat Bone Marrow Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy, ex‐breeder female wistar rats (n = 3) (450–550 g), were the donors. All procedures were carried out according to the UK Home Office Animals Scientific Procedures Act of 1986 and were approved by the Animal Welfare Ethical Review Board at the Royal Veterinary College, and aligned to the ARRIVE guidelines. The rats were euthanized and the femur aseptically isolated. The femoral medullary canal was flushed with 5 ml DMEM 4500 mg/L glucose, (Sigma–Aldrich, UK) with 20% fetal calf serum (FCS) and 1% penicillin/streptomycin (termed “media”), into a 25 cm2 polystyrene cell culture flask (Corning). The cells were cultured in a humidified incubator at 37°C, 95% air and 5% CO2. The media was changed after 5–7 days to remove non‐adherent cells and every 3–4 days thereafter. Once they had reached 70–80% confluence, they were passaged.
+ Open protocol
+ Expand
4

Culture of Human Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell Lines HeLa (CCL-2Ô) cells (human female origin; established cell line, no information on age of the human subject available; see Key Resources Table ) were cultured at 37 C and 7% CO 2 for up to 10 passages in high glucose Dulbecco's Modified Eagle's Medium (DMEM, 4500 mg/L glucose, Sigma-Aldrich) supplemented with 10% (v/v) fetal calf serum (FCS, Biochrom), 1% L-glutamine (Lonza), 100 U/mL penicillin (Lonza) and 100 mg/mL streptomycin (Lonza). Primary human umbilical vein endothelial cells (HUVECs, human female origin; commercially obtained cells from mixed donors, no information on age of the human subjects available; see Key Resources Table ) were cultured at 37 C and 5% CO 2 for up to 4 passages on CellBIND plates (Corning) in 1:1 mixture of Endothelial Cell Growth Medium 2 including supplement (ECGM2, PromoCell) with M199 (Biochrom) supplemented with 10% FCS (Sigma), 30 mg/mL gentamycin (CytoGen), 15 ng/mL amphotericin B (Biochrom) and 100 I:E. Heparin (Sigma Aldrich).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!